Bonum Therapeutics
Focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.
Launch date
Employees
Market cap
-
Enterprise valuation
$372—558m (Dealroom.co estimates Nov 2022.)
Seattle Washington (HQ)
Authorizing premium user...